Literature DB >> 26232180

NR2B-dependent cyclophilin D translocation suppresses the recovery of synaptic transmission after oxygen-glucose deprivation.

Zhihua Zhang1, Yongfu Wang1, Shijun Yan1, Fang Du1, Shirley Shidu Yan1.   

Abstract

N-methyl d-aspartate receptor (NMDA) subunit 2B (NR2B)-containing NMDA receptors and mitochondrial protein cyclophilin D (CypD) are well characterized in mediating neuronal death after ischemia, respectively. However, whether and how NR2B and CypD work together in mediating synaptic injury after ischemia remains elusive. Using an ex vivo ischemia model of oxygen-glucose deprivation (OGD) in hippocampal slices, we identified a NR2B-dependent mechanism for CypD translocation onto the mitochondrial inner membrane. CypD depletion (CypD null mice) prevented OGD-induced impairment in synaptic transmission recovery. Overexpression of neuronal CypD mice (CypD+) exacerbated OGD-induced loss of synaptic transmission. Inhibition of CypD-dependent mitochondrial permeability transition pore (mPTP) opening by cyclosporine A (CSA) attenuated ischemia-induced synaptic perturbation in CypD+ and non-transgenic (non-Tg) mice. The treatment of antioxidant EUK134 to suppress mitochondrial oxidative stress rescued CypD-mediated synaptic dysfunction following OGD in CypD+ slices. Furthermore, OGD provoked the interaction of CypD with P53, which was enhanced in slices overexpressing CypD but was diminished in CypD-null slices. Inhibition of p53 using a specific inhibitor of p53 (pifithrin-μ) attenuated the CypD/p53 interaction following OGD, along with a restored synaptic transmission in both non-Tg and CypD+ hippocampal slices. Our results indicate that OGD-induced CypD translocation potentiates CypD/P53 interaction in a NR2B dependent manner, promoting oxidative stress and loss of synaptic transmission. We also evaluate a new ex vivo chronic OGD-induced ischemia model for studying the effect of oxidative stress on synaptic damage.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CypD; Mitochondria; NR2B; OGD; Synaptic transmission; p53

Year:  2015        PMID: 26232180      PMCID: PMC4872600          DOI: 10.1016/j.bbadis.2015.07.019

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

Review 1.  NMDA receptor pathways as drug targets.

Authors:  John A Kemp; Ruth M McKernan
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

Review 2.  Mitochondria and neuronal death/survival signaling pathways in cerebral ischemia.

Authors:  Pak H Chan
Journal:  Neurochem Res       Date:  2004-11       Impact factor: 3.996

3.  Essential role of SBP-1 activation in oxygen deprivation induced lipid accumulation and increase in body width/length ratio in Caenorhabditis elegans.

Authors:  Changiz Taghibiglou; Henry G S Martin; Jacqueline K Rose; Nadia Ivanova; Conny H C Lin; H Lee Lau; Susan Rai; Yu Tian Wang; Catharine H Rankin
Journal:  FEBS Lett       Date:  2009-01-31       Impact factor: 4.124

4.  DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke.

Authors:  Weihong Tu; Xin Xu; Lisheng Peng; Xiaofen Zhong; Wenfeng Zhang; Mangala M Soundarapandian; Cherine Balel; Manqi Wang; Nali Jia; Wen Zhang; Frank Lew; Sic Lung Chan; Yanfang Chen; Youming Lu
Journal:  Cell       Date:  2010-01-22       Impact factor: 41.582

5.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

Review 6.  Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?

Authors:  Benedict C Albensi; Chiazor Igoechi; Damir Janigro; Erin Ilkanich
Journal:  Am J Alzheimers Dis Other Demen       Date:  2004 Sep-Oct       Impact factor: 2.035

Review 7.  Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging.

Authors:  Claude Messier
Journal:  Neurobiol Aging       Date:  2005-10-19       Impact factor: 4.673

Review 8.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

9.  Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries.

Authors:  Changiz Taghibiglou; Henry G S Martin; Ted Weita Lai; Taesup Cho; Shiv Prasad; Luba Kojic; Jie Lu; Yitao Liu; Edmund Lo; Shu Zhang; Julia Z Z Wu; Yu Ping Li; Yan Hua Wen; Joon-Hyuk Imm; Max S Cynader; Yu Tian Wang
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

10.  Cyclosporin A protects against ischemia-reperfusion injury in the brain.

Authors:  Y Shiga; H Onodera; Y Matsuo; K Kogure
Journal:  Brain Res       Date:  1992-11-06       Impact factor: 3.252

View more
  4 in total

1.  Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.

Authors:  Qing Yu; Fang Du; Justin T Douglas; Haiyang Yu; Shirley ShiDu Yan; Shi Fang Yan
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Mitochondrial Perturbation in Alzheimer's Disease and Diabetes.

Authors:  F Akhter; D Chen; S F Yan; S S Yan
Journal:  Prog Mol Biol Transl Sci       Date:  2017-02-04       Impact factor: 3.622

3.  Anxiety and task performance changes in an aging mouse model.

Authors:  Erika D Nolte; Keith A Nolte; Shirley ShiDu Yan
Journal:  Biochem Biophys Res Commun       Date:  2019-04-24       Impact factor: 3.575

4.  Disease Outcome and Brain Metabolomics of Cyclophilin-D Knockout Mice in Sepsis.

Authors:  Takayuki Kobayashi; Hiroyuki Uchino; Eskil Elmér; Yukihiko Ogihara; Hidetoshi Fujita; Shusuke Sekine; Yusuke Ishida; Iwao Saiki; Shoichiro Shibata; Aya Kawachi
Journal:  Int J Mol Sci       Date:  2022-01-16       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.